These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34383045)

  • 1. Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Viola V; Leanza G; Tramontana F
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5271-e5272. PubMed ID: 34383045
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Nogues X; Quesada-Gomez JM; Garcia-Giralt N
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5281-e5282. PubMed ID: 34331760
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
    Jayaram A; Buhimschi IA; Buhimschi CS
    Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].
    Martins TGDS
    Acta Med Port; 2021 Jan; 34(1):63. PubMed ID: 33092689
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging pulmonary histopathological findings in COVID-19 patients- a letter to the editor in response to Grosse et al. 2020.
    Parmar D; Ponnampalam J; Seligmann G; Gandhi T
    Cardiovasc Pathol; 2021; 51():107302. PubMed ID: 33152459
    [No Abstract]   [Full Text] [Related]  

  • 6. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].
    Thompson KM; Kalkowska DA; Badizadegan K
    Risk Anal; 2021 Feb; 41(2):389-392. PubMed ID: 33590518
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: "
    Rani R
    Assay Drug Dev Technol; 2021 Oct; 19(7):408-409. PubMed ID: 34463124
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the Editor in Response to Khazanchi et al.
    Nayak A; Islam SJ; Mehta A; Quyyumi AA
    J Gen Intern Med; 2021 Apr; 36(4):1113-1114. PubMed ID: 33469749
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor From Singhania et al: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults".
    Singhania P; Bhattacharjee R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2202-e2203. PubMed ID: 35018443
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).
    Singh A; Shaikh A; Singh R; Singh AK
    Diabetes Metab Syndr; 2020; 14(5):865. PubMed ID: 32562863
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor in response to article: Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis (Martha et al.).
    Siniorakis EE; Arvanitakis SG; Elkouris MJ
    Diabetes Metab Syndr; 2021; 15(3):1059-1060. PubMed ID: 33814294
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the editor regarding article: Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India (Rawat et al.).
    Mirzaei F; Tavilani A; Abbasi-Oshaghi E
    Diabetes Metab Syndr; 2021; 15(3):1053-1054. PubMed ID: 33895088
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the editor regarding the article ''Rossi A, Magri F, Michelini S, et al. New onset of alopecia areata in a patient with SARS-COV-2 infection: Possible pathogenetic correlations? J Cosmet Dermatol. 2021 Mar 19. doi: 10.1111/jocd.14080".
    Abou-Rahal J; Abdullah L; Kurban M; Abbas O
    J Cosmet Dermatol; 2021 Jun; 20(6):1951-1952. PubMed ID: 33853206
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the Editor in regard to the "Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome" by Roedl et al.".
    Krieg AD; Duval-Arnould J; Newton H; Winters BD; Hunt EA
    Scand J Trauma Resusc Emerg Med; 2021 Nov; 29(1):159. PubMed ID: 34732229
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the editor in response to Buja et al. 2020.
    Parmar D; Gandhi T; Ahmad M; Kirresh A; Seligmann G
    Cardiovasc Pathol; 2021; 50():107269. PubMed ID: 32871258
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the editor in response to the article: "Vitamin D concentrations and COVID-19 infection in UK biobank" (Hastie et al.).
    Davies G; Mazess RB; Benskin LL
    Diabetes Metab Syndr; 2021; 15(2):643-644. PubMed ID: 33722481
    [No Abstract]   [Full Text] [Related]  

  • 18. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Response to the Letter from the Editor by Velasco Montes et al.
    Elola-Somoza FJ; Bas-Villalobos MC; Pérez-Villacastín J; Macaya-Miguel C
    Rev Clin Esp (Barc); 2022 Jan; 222(1):56-57. PubMed ID: 34799280
    [No Abstract]   [Full Text] [Related]  

  • 19. Response letter: Letter to the editor regarding Wei W et al.: ''Experience of the Hubei cancer hospital in Wuhan, China".
    Bi J; Wei W; Hu D; Han G
    Radiother Oncol; 2021 Feb; 155():e8-e9. PubMed ID: 32898560
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor: Comment on Mulder J et al. (2021) indirect immunofluorescence for detecting anti-neuronal autoimmunity in CSF after COVID-19 - possibilities and pitfalls.
    Franke C; Prüss H
    Brain Behav Immun; 2021 May; 94():475. PubMed ID: 33639240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.